ArticleScientific reports2024

A fractional-order model for optimizing combination therapy in heterogeneous lung cancer: integrating immunotherapy and targeted therapy to minimize side effects.

David Amilo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.